Mapping early conformational changes in αIIb and β3 during biogenesis reveals a potential mechanism for αIIbβ3 adopting its bent conformation

Blood

Volumn 109, Issue 9, 2007, Pages 3725-3732

  Mitchell, W Beau ^a,b,f   Li, Jihong ^b   Murcia, Marta ^b,c   Valentin, Nathalie ^d   Newman, Peter J ^e   Coller, Barry S ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e BLOOD RESEARCH INSTITUTE   (United States)

^f NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; BETA3 INTEGRIN; MONOCLONAL ANTIBODY;

ARTICLE; BIOGENESIS; CELL STRAIN HEK293; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIGAND BINDING; MEGAKARYOCYTE; PRIORITY JOURNAL;

EID: 34247389664     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-11-058420     Document Type: Article

References (58)

1. Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood. 2004;104:1606-1615.
2. Coller BS. Anti-GPIIb/IIIa drugs: current strategies and future directions. Thromb Haemost. 2001;86:427-443.
3. McEver RP, Baenziger JU, Majerus PW. Isolation and structural characterization of the polypeptide subunits of membrane glycoprotein IIb-IIIa from human platelets. Blood. 1982;59:80-85.
4. Bray PF, Rosa JP, Lingappa VR, Kan YW, McEver RP, Shuman MA. Biogenesis of the platelet receptor for fibrinogen: evidence for separate precursors for glycoproteins IIb and IIIa. Proc Natl Acad Sci U S A. 1986;83:1480-1484.
5. Wencel-Drake JD, Plow EF, Kunicki TJ, Woods VL, Keller DM, Ginsberg MH. Localization of internal pools of membrane glycoproteins involved in platelet adhesive responses. Am J Pathol. 1986;124:324-334.
6. Woods VL Jr, Wolff LE, Keller DM. Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not other extracellular proteins. J Biol Chem. 1986;261:15242- 15251.
7. Duperray A, Berthier R, Chagnon E, et al. Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes. J Cell Biol. 1987;104:1665-1673.
8. Silver SM, McDonough MM, Vilaire G, Bennett JS. The in vitro synthesis of polypeptides for the platelet membrane glycoproteins IIb and IIIa. Blood. 1987;69:1031-1037.
9. Rosa J-P, McEver RP. Processing and assembly of the integrin, glycoprotein IIb-IIIa, in HEL cells. J Biol Chem. 1989;264:12596-12603.
10. Duperray A, Troesch A, Berthier R, et al. Biosynthesis and assembly of platelet GPIIb-IIIa in human megakaryocytes: evidence that assembly between pro-GPIIb and GPIIIa is a prerequisite for expression of the complex on the cell surface. Blood. 1989;74:1603-1611.
11. Wencel-Drake JD. Plasma membrane GPIIb/IIIa. Evidence for a cycling receptor pool. Am J Pathol. 1990;136:61-70.
12. Xiong J-P, Stehle T, Diefenbach B, et al. Crystal structure of the extracellular segment of integrin alphaVbeta3. Science. 2001;294:339-345.
13. Takagi J, Petre BM, Walz T, Springer TA. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell. 2002;110:599-511.
14. Takagi J, Springer TA. Integrin activation and structural rearrangement. Immunol Rev. 2002;186:141-163.
15. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature. 2004;432:59-67.
16. Mitchell WB, Li J, French DL, Coller BS. alphaIIb-beta3 Biogenesis is controlled by engagement of alphaIIb in the calnexin cycle via the N15-linked glycan. Blood. 2006;107:2713-2719.
17. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds glycoproteins IIb and/or IIIa. J Clin Invest. 1983;72:325-338.
18. Shadle PJ, Ginsberg MH, Plow EF, Barondes SH. Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb. J Cell Biol. 1984;99:2056-2060.
19. Coller BS. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. J Clin Invest. 1985;76:101-108.
20. Newman PJ, Allen RW, Kahn RA, Kunicki TJ. Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP-3. Blood. 1985;65:227-232.
21. Ginsberg MH, Lightsey A, Kunicki TJ, Kaufmann A, Marguerie G, Plow EF. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. J Clin Invest. 1986;78:1103-1111.
22. Frelinger ALI, Cohen I, Plow EF, et al. Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J Biol Chem. 1990;265:6346-6352.
23. Kutok JL, Coller BS. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency. Thromb Haemost. 1994;72:964-972.
24. Kouns WC, Steiner B, Kunicki TJ, et al. Activation of the fibrinogen binding site on platelets isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia. Blood. 1994;84:1108-1115.
25. 3 subunit. J Biol Chem. 1995;270:11947-11954.
26. Southern JA, Young DF, Heaney F, Baumgartner WK, Randall RE. Identification of an epitope on the P and V proteins of simian virus 5 that distinguishes between two isolates with different biological characteristics. J Gen Virol. 1991;72(pt 7):1551-1557.
27. Frelinger AL III, Lam SC, Plow EF, Smith MA, Loftus JC, Ginsberg MH. Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem. 1988;263:12397-12402.
28. 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J Biol Chem. 1991;266:17106-17111.
29. Peterson JA, Visentin GP, Newman PJ, Aster RH. A recombinant soluble form of the integrin alpha IIb beta 3 (GPIIb-IIIa) assumes an active, ligand-binding conformation and is recognized by GPIIb-IIIa-specific monoclonal, allo-, auto-, and drug-dependent platelet antibodies. Blood. 1998;92:2053-2063.
30. Artoni A, Li J, Mitchell B, et al. Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIb-beta3 activation. Proc Natl Acad Sci U S A. 2004;101:13114-13120.
31. Kouns WC, Newman PJ, Puckett KJ, et al. Further characterization of the loop structure of platelet glycoprotein IIIa: partial mapping of functionally significant glycoprotein IIIa epitopes. Blood. 1991;78:3215-3223.
32. Kekomaki R, Dawson B, McFarland J, Kunicki TJ. Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa. J Clin Invest. 1991;88:847-854.
33. Du X, Gu M, Weisel JW, et al. Long range propagation of conformational changes in integrin alpha IIb beta 3. J Biol Chem. 1993;268:23087-23092.
34. Mitchell WB, Li JH, Singh F, et al. Two novel mutations in the alpha IIb calcium-binding domains identify hydrophobic regions essential for alpha IIbbeta 3 biogenesis. Blood. 2003;101:2268-2276.
35. Fiser A, Sali A. Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol. 2003;374:461-491.
36. Xiong JP, Stehle T, Goodman SL, Arnaout MA. A novel adaptation of the integrin PSI domain revealed from its crystal structure. J Biol Chem. 2004;279:40252-40254.
37. Shi M, Sundramurthy K, Liu B, Tan SM, Law SK, Lescar J. The crystal structure of the plexinsemaphorin-integrin domain/hybrid domain/IEGF1 segment from the human integrin beta2 subunit at 1.8-A resolution. J Biol Chem. 2005;280:30586-30593.
38. Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26:1701-1718.
39. Kim DE, Chivian D, Baker D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res. 2004;32:W526-W531.
40. Simons KT, Kooperberg C, Huang E, Baker D. Assembly of protein tertiary structures from fragments with similar local sequences using simulated annealing and Bayesian scoring functions. J Mol Biol. 1997;268:209-225.
41. Rohl CA, Strauss CE, Chivian D, Baker D. Modeling structurally variable regions in homologous proteins with rosetta. Proteins. 2004;55:656-677.
42. Chivian D, Kim DE, Malmstrom L, Schonbrun J, Rohl CA, Baker D. Prediction of CASP6 structures using automated Robetta protocols. Proteins. 2005;61(suppl 7):157-166.
43. Coller BS, Peerschke EI, Seligsohn U, Scudder LE, Nurden AT, Rosa JP. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor. J Lab Clin Med. 1986;107:384-392.
44. Peterson JA, Contessa EN, Newman PJ, Aster RH. A site involving the "hybrid" and PSI homology domains of GPIIIa (β3-integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia. Blood. 2003;101:937-942.
45. Honda S, Tomiyama Y, Aoki T, et al. Association between ligand-induced conformational changes of integrin IIbbeta3 and IIbbeta3-mediated intracellular Ca2+ signaling. Blood. 1998;92:3675-3683.
46. Loftus JC, Plow EF, Frelinger ALI, et al. Molecular cloning and chemical synthesis of a region of platelet glycoprotein IIb involved in adhesive function. Proc Natl Acad Sci U S A. 1987;84:7114-7118.
47. Xiong JP, Stehle T, Zhang R, et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science. 2002;296:151-155.
48. Huang C, Springer TA. Folding of the beta-propeller domain of the integrin alphaL subunit is independent of the I domain and dependent on the beta2 subunit. Proc Natl Acad Sci U S A. 1997;94:3162-3167.
49. Huang C, Lu C, Springer TA. Folding of the conserved domain but not of flanking regions in the integrin beta2 subunit requires association with the alpha subunit. Proc Natl Acad Sci U S A. 1997;94:3156-3161.
50. Fiser A, Do RK, Sali A. Modeling of loops in protein structures. Protein Sci. 2000;9:1753-1773.
51. Calzada MJ, Alvarez MV, Gonzalez-Rodriguez J. Agonist-specific structural rearrangements of integrin alpha IIbbeta 3. Confirmation of the bent conformation in platelets at rest and after activation. J Biol Chem. 2002;277:39899-39908.
52. Fujimura K, Phillips DR. Calcium cation regulation of glycoprotein IIb-IIIa complex formation in platelet plasma membranes. J Biol Chem. 1983;258:10247-10252.
53. Phillips DR, Fujimura K, Jennings LK, Parise L, Fitzgerald L, Fox JE. Calcium regulation of glycoproteins IIb and IIIa in human platelet membranes. Ann N Y Acad Sci. 1983;416:166-175.
54. Williams DB. Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum. J Cell Sci. 2006;119:615-623.
55. Coller BS. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest. 1997;100:S57-S60.
56. Marecki S, Kirkpatrick P. Efalizumab. Nat Rev Drug Discov. 2004;3:473-474.
57. Macdonald JK, McDonald JW. Natalizumab for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2006;3:CD006097.
58. Hohlfeld R, Wekerle H. Drug insight: using monoclonal antibodies to treat multiple sclerosis. Nat Clin Pract Neurol. 2005;1:34-44.